| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.67B | -13.7% |
| Cost of Revenue | $1.50B | -2.4% |
| Gross Profit | $164.9M | -57.8% |
| R&D Expense | $18.0M | +20.0% |
| SG&A Expense | $211.2M | -8.7% |
| Operating Income | -$56.0M | -135.1% |
| Interest Expense | $17.1M | +1.2% |
| Pre-tax Income | -$72.9M | -154.4% |
| Income Tax | -$23.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $194.7M | -40.6% |
| Accounts Receivable | $295.2M | +17.0% |
| Inventory | $564.6M | -7.2% |
| Current Assets | $1.12B | -10.0% |
| Total Assets | $1.84B | -5.0% |
| Current Liabilities | $370.8M | +13.5% |
| Long-term Debt | $440.9M | +3.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.5M | -93.3% |
| Capital Expenditures | $47.4M | -25.0% |
| Investing Cash Flow | -$47.4M | +24.9% |
| Financing Cash Flow | -$91.6M | -0.1% |
| Free Cash Flow | -$41.9M | -326.5% |
| -181.0% |
| Net Income | -$49.1M | -147.0% |
| EPS (Basic) | -$0.43 | -147.8% |
| EPS (Diluted) | -$0.43 | -147.8% |
| Stockholders' Equity |
| $808.3M |
| -15.6% |